Literature DB >> 3885691

Abdominal lymphadenopathy in intravenous drug addicts: sonographic features and clinical significance.

B R Subramanyam, E J Balthazar, S C Horii, S Hilton.   

Abstract

The sonographic features of abdominal lymphadenopathy in 35 patients with history of intravenous drug addiction were analyzed to assess their clinical significance. Of the 28 proven cases, 15 were due to reactive hyperplasia, 10 to infections, and three to neoplasms. Sonography was helpful in assessing the pathologic nature of these nodes. Most nodes attributable to reactive hyperplasia were small (less than or equal to 1.5 cm diam) and showed a characteristic distribution in the porta hepatis, celiac axis, and peripancreatic regions. Hypoechoic nodes were always pathologic, due either to tuberculosis or to neoplasm. Nodes larger than 1.5 cm in diameter and primarily involving the lower retroperitoneum, splenic hilum, and mesentery are highly suspicious for pathologic nodes, and appropriate biopsies are indicated for diagnosis.

Entities:  

Mesh:

Year:  1985        PMID: 3885691     DOI: 10.2214/ajr.144.5.917

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  3 in total

1.  Transabdominal ultrasonography in preoperative staging of gastric cancer.

Authors:  Sheng-Ri Liao; Ying Dai; Ling Huo; Kun Yan; Lin Zhang; Hui Zhang; Wen Gao; Min-Hua Chen
Journal:  World J Gastroenterol       Date:  2004-12-01       Impact factor: 5.742

2.  The value of dynamic imaging for standardization of abdominal ultrasonography.

Authors:  Sachiyo Inamura; Fumio Tsujimoto; Takanori Okamura; Masaru Sakurai; Shinichi Nakaya; Osamu Ishii; Sachihiko Nobuoka; Takahide Matsuda
Journal:  J Med Ultrason (2001)       Date:  2012-01-21       Impact factor: 1.314

3.  Retroperitoneal lymphadenopathy: an extrahepatic feature of chronic active hepatitis.

Authors:  T Hayek; A Markel; M Goldfeld; Y Ben-Arie; G J Brook
Journal:  Postgrad Med J       Date:  1994-05       Impact factor: 2.401

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.